Phoebe loh qiagen
WebbPhoebe Loh. Senior Director Investor Relations. +49 2103 29 11457. [email protected]. Download VCARD. Alexandra Koenig. Investor Relations … Webb14 apr. 2024 · 20-F. Weitere Informationen finden Sie in Berichten, die QIAGEN bei der U.S. Securities and Exchange Commission (US-Börsenaufsichtsbehörde) eingereicht hat. Kontakte QIAGEN: Investor Relations Public Relations. John Gilardi +49 2103 29 11711 Thomas Theuringer +49 2103 29 11826. Phoebe Loh +49 2103 29 11457 Daniela Eltrop …
Phoebe loh qiagen
Did you know?
Webbför 18 timmar sedan · QIAGEN präsentiert neueste Technologien für die Krebsforschung beim Jahrestreffen der American Association for Cancer Research. ... John Gilardi Phoebe Loh +49 2103 29 11711 +49 2103 29 11457: Webb14 feb. 2024 · QFT-Plus is QIAGEN’s trusted test, endorsed by the WHO, that aids in indirect detection of the bacteria that causes tuberculosis (TB). The IVDR certification of QFT-Plus follows the QIAGEN...
Webb28 maj 2024 · QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. WebbPhoebe LOH, Global Product Manager Cited by 1,983 of QIAGEN, Hilden Read 6 publications Contact Phoebe LOH
Webbför 18 timmar sedan · Source: QIAGEN N.V. Category: Corporate Contact Data John Gilardi QIAGEN N.V. +49 2103 29 11711 [email protected] Phoebe Loh QIAGEN N.V. +49 2103 29 … WebbPhoebe Loh is on Facebook. Join Facebook to connect with Phoebe Loh and others you may know. Facebook gives people the power to share and makes the world more open …
Webb27 mars 2024 · Source: QIAGEN N.V. Category: Corporate John Gilardi QIAGEN N.V. +49 2103 29 11711 [email protected] Phoebe Loh QIAGEN N.V. +49 2103 29 11457 [email protected] Thomas Theuringer QIAGEN N.V. +49 2103 29 11826 [email protected] Daniela Eltrop QIAGEN N.V. +49 2103 29 11676 [email protected] No more messages to …
Webb29 juni 2024 · QIAGEN Investor Relations John Gilardi +49 2103 29 11711 Phoebe Loh +49 2103 29 11457 [email protected]. Public Relations Thomas Theuringer +49 2103 29 … ctvcatchWebb13 apr. 2024 · ^VENLO, Niederlande, April 14, 2024 -- QIAGEN hat heute die Einführung seiner QIAseq Targeted cfDNA Ultra Panels bekannt gegeben. Mit... 14 April 2024 ... Public Relations John Gilardi +49 2103 29 11711 Thomas Theuringer +49 2103 29 11826 Phoebe Loh +49 2103 29 11457 Daniela Eltrop +49 2103 29 11676 E-Mail ... ctv canterbury televisioneasiersoft barcode generatorWebb30 juni 2024 · QIAGEN Investor Relations John Gilardi +49 2103 29 11711 Phoebe Loh +49 2103 29 11457 e-mail: [email protected] Public Relations Thomas Theuringer +49 2103 29 11826 Robert Reitze +49 2103 29... ctv.ca news winnipegWebb7 jan. 2024 · QIAGEN: Investor Relations John Gilardi, +49 2103 29 11711 Phoebe Loh, +49 2103 29 11457 [email protected]. Public Relations Thomas Theuringer, +49 2103 29 … ctv cape townWebb14 apr. 2024 · QIAGEN präsentiert neueste Technologien für die Krebsforschung beim Jahrestreffen der American Association for Cancer Research. QIAGEN Aktie [WKN: 901626 / ISIN: NL0012169213] ... John Gilardi Phoebe Loh +49 2103 29 11711 +49 2103 29 11457: Thomas Theuringer Daniela Eltrop ctv catch upWebbQIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, ... Phoebe Loh +49.2103.29.11457 Robert Reitze +49.2103.29.11676 [email protected] [email protected] . Title: Microsoft Word - CS DiaSorin - Calpro_FDA_ITA ctv.ca news live